A61K 31/351
Not condensed with another ring
Official title: not condensed with another ring
A61K31/351 (Not condensed with another ring) appears on 856 US grants and 1,615 published applications in this corpus.
Search patents in A61K- Granted patents
- 856
- Published applications
- 1,615
- Assignees
- 827
- Inventors
- 3,537
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 5 | 0 |
| 1999 | 7 | 0 |
| 2000 | 8 | 0 |
| 2001 | 12 | 3 |
| 2002 | 17 | 17 |
| 2003 | 8 | 21 |
| 2004 | 8 | 23 |
| 2005 | 13 | 25 |
| 2006 | 9 | 27 |
| 2007 | 18 | 25 |
| 2008 | 5 | 38 |
| 2009 | 6 | 39 |
| 2010 | 16 | 44 |
| 2011 | 13 | 64 |
| 2012 | 19 | 47 |
| 2013 | 32 | 80 |
| 2014 | 51 | 92 |
| 2015 | 49 | 75 |
| 2016 | 64 | 92 |
| 2017 | 54 | 99 |
| 2018 | 46 | 94 |
| 2019 | 63 | 99 |
| 2020 | 75 | 105 |
| 2021 | 69 | 96 |
| 2022 | 38 | 89 |
| 2023 | 47 | 87 |
| 2024 | 35 | 95 |
| 2025 | 41 | 88 |
| 2026 | 25 | 51 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions comprising HDAC inhibitors and retinoids22 Sep 2026US 12,740,953 B2The Regents of the University of California
- Sotagliflozin for improving left atrial function22 Sep 2026US 12,740,965 B2Lexicon Pharmaceuticals, Inc.
- Use of membrane inhibitors to enhance vaccine development against enveloped viruses8 Sep 2026US 12,728,161 B2Cornell University
- Bacterial DNA gyrase inhibitors and methods of use thereof25 Aug 2026US 12,714,692 B2The Florida International University Board of Trustees
- Methods for improving renal function with a combination of a bet bromodomain inhibitor and a sodium dependent glucose transport 2 inhibitor7 Jul 2026US 12,673,059 B2Resverlogix Corp.
- Water-based liquid preparation8 Oct 2026US 2026/0306443 A1Senju USA, Inc.
- Novel carboxamide derivatives8 Oct 2026US 2026/0308149 A1Angelini Pharma S.P.A.
- Hexahydro[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine deuterated derivative, pharmaceutical composition thereof, preparation method therefor, and anti-influenza use thereof8 Oct 2026US 2026/0308174 A1Changsha Jingyi Pharmaceutical Technology Co., Ltd
- Crystalline complexes between velagliflozin and selected co-crystal forming agents, methods for their preparation and the use thereof for preparing medicaments24 Sep 2026US 2026/0285825 A1Boehringer Ingelheim Vetmedica GmbH
- Collagen peptide-based medicament compositions and devices and methods of production and use thereof17 Sep 2026US 2026/0273015 A1Sustain Holdings, LLC
Most cited
By later US patents
- Pharmaceutical and cosmetic carrier or composition for topical application284US 6,911,211 B2Foamix Ltd. · 2005
- Oleaginous pharmaceutical and cosmetic foam202US 7,820,145 B2Foamix Ltd. · 2010
- Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses170US 8,486,374 B2Foamix Ltd. · 2013
- Amino acid complexes of C-aryl glucosides for treatment of diabetes and method153US 6,774,112 B2Bristol-Myers Squibb Company · 2004
- Use of sulfamate derivatives for treating impulse control disorders114US 6,323,236 B2University of Cincinnati · 2001